Which has grown faster, INMD or PACB?

Over the past five years, PACB grew revenue faster — INMD at a 5.42% CAGR versus PACB at 8.52%.

Is INMD or PACB more profitable?

INMD runs the higher net margin — INMD at 20.69% versus PACB at -82.49%.

How have INMD and PACB total returns compared?

Over the past 5 years, INMD delivered -27.48% and PACB delivered -35.20% annualized total return. Past performance doesn't predict future results.

InMode Ltd. (INMD) vs Pacific Biosciences of California, Inc. (PACB)

A side-by-side comparison of InMode Ltd. and Pacific Biosciences of California, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INMD

InMode Ltd.

$803M

$13.97HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

PACB

Pacific Biosciences of California, Inc.

$842M

$2.71HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — INMD vs PACB

growth of $100 · dividends reinvested · last 7y

INMD +108.1% (+11.0%/yr)PACB -47.1% (-8.7%/yr)INMD compounded faster over this window

INMD PACB

INMD vs PACB: by the numbers

•PACB is the larger company ($842M vs $803M market cap).
•INMD is profitable (20.69% net margin) while PACB runs a net loss (-82.49%).
•PACB grew revenue faster over the past five years (8.52% vs 5.42% CAGR).

Metrics side by side

Valuation

Metric	INMD	PACB
P/E ratio	11.35	N/A
Forward P/E	10.78	N/A
PEG ratio	1.14	N/A
P/S ratio	2.14	5.29
P/B ratio	1.28	N/A
EV / EBITDA	5.88	N/A
FCF yield	10.89%	N/A

Profitability

Metric	INMD	PACB
Gross margin	76.52%	35.97%
Operating margin	18.47%	-348.46%
Net margin	20.69%	-82.49%
ROE	12.32%	N/A
ROIC	9.20%	-23.80%

Growth (annualized)

Metric	INMD	PACB
Revenue CAGR (5Y)	5.42%	8.52%
EPS CAGR (5Y)	6.87%	N/A
FCF CAGR (5Y)	1.36%	N/A
Total return CAGR (5Y)	-27.48%	-35.20%

Frequently asked

Which has grown faster, INMD or PACB?: Over the past five years, PACB grew revenue faster — INMD at a 5.42% CAGR versus PACB at 8.52%.
Is INMD or PACB more profitable?: INMD runs the higher net margin — INMD at 20.69% versus PACB at -82.49%.
How have INMD and PACB total returns compared?: Over the past 5 years, INMD delivered -27.48% and PACB delivered -35.20% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INMD analysis Full PACB analysis Interactive comparison tool

Dig into the metrics

InMode P/E ratio InMode ROE Pacific Biosciences of California ROE InMode operating margin Pacific Biosciences of California operating margin InMode revenue growth Pacific Biosciences of California revenue growth InMode free cash flow Pacific Biosciences of California free cash flow

InMode & Pacific Biosciences of California appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.